104 related articles for article (PubMed ID: 36911042)
1. Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data.
Alexeeva E; Krekhova E; Dvoryakovskaya T; Isaeva K; Chomakhidze A; Chistyakova E; Lomakina O; Denisova R; Mamutova A; Fetisova A; Gautier M; Vankova D; Kriulin I; Saygitov R
Front Pediatr; 2023; 11():1114207. PubMed ID: 36911042
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience.
Qiu L; Ma L; Xie Y; Jin J; Pan Y; Li S; Fan Z; Yu H
Pediatr Rheumatol Online J; 2024 Mar; 22(1):38. PubMed ID: 38504360
[TBL] [Abstract][Full Text] [Related]
3. Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China.
Zhu X; Weng R; Huang Y; Xu Y; Yang J; He T
Front Pediatr; 2024; 12():1349907. PubMed ID: 38550627
[TBL] [Abstract][Full Text] [Related]
4. Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study.
Belozerov KE; Solomatina NM; Isupova EA; Kuznetsova AA; Kostik MM
World J Clin Pediatr; 2024 Mar; 13(1):88912. PubMed ID: 38596441
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study.
Iwata N; Nishimura K; Hara R; Imagawa T; Shimizu M; Tomiita M; Umebayashi H; Takei S; Seko N; Wakabayashi R; Yokota S
Mod Rheumatol; 2023 Nov; 33(6):1162-1170. PubMed ID: 36399020
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner HI; Ruperto N; Ramanan AV; Horneff G; Minden K; Calvo Penades I; Alexeeva E; Cleary G; Stern SM; Kone-Paut I; Maldonado Velázquez MDR; Rabinovich CE; Remesal A; Silva CA; Nikishina I; Zucchetto M; Brockwell L; Gordon O; Nagel S; De Benedetti F;
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38552315
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of an early response-based tapering regimen of tocilizumab in children with systemic juvenile idiopathic arthritis.
Dey S; Roy D; Sinhamahapatra P; Ghosh A
Int J Rheum Dis; 2024 May; 27(5):e15196. PubMed ID: 38769886
[TBL] [Abstract][Full Text] [Related]
8. Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005-2021).
Foley CM; McKenna D; Gallagher K; McLellan K; Alkhdher H; Lacassagne S; Moraitis E; Papadopoulou C; Pilkington C; Al Obaidi M; Eleftheriou D; Brogan P
Front Pediatr; 2023; 11():1218312. PubMed ID: 37780048
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study.
Alexeeva E; Shingarova M; Dvoryakovskaya T; Lomakina O; Fetisova A; Isaeva K; Chomakhidze A; Chibisova K; Krekhova E; Kozodaeva A; Savostyanov K; Pushkov A; Zhanin I; Demyanov D; Suspitsin E; Belozerov K; Kostik M
Front Med (Lausanne); 2023; 10():1257045. PubMed ID: 38034538
[TBL] [Abstract][Full Text] [Related]
10. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study.
Coşkuner T; Çağlayan Ş; Akgün Ö; Torun R; Yayla ENS; Bagrul IL; Kılbaş G; Yener GO; Köse H; Öztürk K; Baba Ö; Çakan M; Demir F; Sönmez HE; Kalyoncu M; Kılıç SS; Yüksel S; Bağlan E; Bakkaloğlu SA; Ünsal E; Aktay Ayaz N; Sözeri B
Expert Opin Biol Ther; 2023; 23(12):1299-1306. PubMed ID: 37970654
[TBL] [Abstract][Full Text] [Related]
11. IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).
Bielak M; Husmann E; Weyandt N; Haas JP; Hügle B; Horneff G; Neudorf U; Lutz T; Lilienthal E; Kallinich T; Tenbrock K; Berendes R; Niehues T; Wittkowski H; Weißbarth-Riedel E; Heubner G; Oommen P; Klotsche J; Foell D; Lainka E
Pediatr Rheumatol Online J; 2018 Apr; 16(1):22. PubMed ID: 29622022
[TBL] [Abstract][Full Text] [Related]
12. IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis.
Giancane G; Minoia F; Davì S; Bracciolini G; Consolaro A; Ravelli A
Front Pharmacol; 2016; 7():467. PubMed ID: 27999545
[TBL] [Abstract][Full Text] [Related]
13. Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients with Congenital Heart Disease.
Pontes Aires B; Wobma H; Samad A; Chandler MT; Chang MH; Dedeoglu F; Fishman MP; Klouda T; Levin J; Halyabar O; Saleeb SF; Tworetzky W; Son MBF; Newburger JW; Casey A; Henderson LA
J Rheumatol; 2024 Jun; ():. PubMed ID: 38825355
[TBL] [Abstract][Full Text] [Related]
14. Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.
Salugina SO; Torgashina AV; Borzova EY; Rameev VV; Gorodetsky VR; Fedorov ES; Muravyova NV
Dokl Biochem Biophys; 2024 Jun; ():. PubMed ID: 38861148
[TBL] [Abstract][Full Text] [Related]
15. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management.
Swanson C; Khan EK; Cooper A; Ibarra M; Tam-Williams J
Pediatr Pulmonol; 2024 Mar; 59(3):724-733. PubMed ID: 38155594
[TBL] [Abstract][Full Text] [Related]
16. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.
Huang Y; Sompii-Montgomery L; Patti J; Pickering A; Yasin S; Do T; Baker E; Gao D; Abdul-Aziz R; Behrens EM; Canna S; Clark M; Co DO; Collins KP; Eberhard B; Friedman M; Graham TB; Hahn T; Hersh AO; Hobday P; Holland MJ; Huggins J; Lu PY; Mannion ML; Manos CK; Neely J; Onel K; Orandi AB; Ramirez A; Reinhardt A; Riskalla M; Santiago L; Stoll ML; Ting T; Grom AA; Towe C; Schulert GS
Arthritis Care Res (Hoboken); 2024 Mar; 76(3):328-339. PubMed ID: 37691306
[TBL] [Abstract][Full Text] [Related]
17. A decade of progress in juvenile idiopathic athritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Nguyen K; Barsalou J; Basodan D; Batthish M; Benseler SM; Berard RA; Blanchette N; Boire G; Bolaria R; Bruns A; Cabral DA; Cameron B; Campillo S; Cellucci T; Chan M; Chédeville G; Chetaille AL; Chhabra A; Couture J; Dancey P; De Bruycker JJ; Demirkaya E; Dhalla M; Duffy CM; Feldman BM; Feldman DE; Gerschman T; Haddad E; Heale L; Herrington J; Houghton K; Huber AM; Human A; Johnson N; Jurencak R; Lang B; Larché M; Laxer RM; LeBlanc CM; Lee JJY; Levy DM; Lim L; Lim LSH; Luca N; McGrath T; McMillan T; Miettunen PM; Morishita KA; Ng HY; Oen K; Park J; Petty RE; Proulx-Gauthier JP; Ramsey S; Roth J; Rosenberg AM; Rozenblyum E; Rumsey DG; Schmeling H; Schneider R; Scuccimarri R; Shiff NJ; Silverman E; Soon G; Spiegel L; Stringer E; Tam H; Tse SM; Tucker L; Turvey S; Twilt M; Duffy KW; Yeung RSM; Guzman J;
Rheumatology (Oxford); 2023 Oct; ():. PubMed ID: 37851400
[TBL] [Abstract][Full Text] [Related]
18. Treatment of systemic-onset juvenile arthritis with canakinumab.
Peitz J; Horneff G
Open Access Rheumatol; 2015; 7():23-31. PubMed ID: 27790042
[TBL] [Abstract][Full Text] [Related]
19. Systemic arthritis in children: a review of clinical presentation and treatment.
Gurion R; Lehman TJ; Moorthy LN
Int J Inflam; 2012; 2012():271569. PubMed ID: 22235382
[TBL] [Abstract][Full Text] [Related]
20. Defining Criteria for Disease Activity States in Systemic Juvenile Idiopathic Arthritis Based on the Systemic Juvenile Arthritis Disease Activity Score.
Rosina S; Rebollo-Giménez AI; Tarantola L; Pistorio A; Vyzhga Y; El Miedany Y; Lotfy HM; Abu-Shady H; Eissa M; Osman NS; Hassan W; Mahgoub MY; Fouad NA; Mosa DM; Adel Y; Mohamed SEM; Radwan AR; Abu-Zaid MH; Tabra SAA; Shalaby RH; Nasef SI; Khubchandani R; Khan A; Maldar NP; Ozen S; Bayindir Y; Alsuweiti M; Alzyoud R; Almaaitah H; Vilaiyuk S; Lerkvaleekul B; Alexeeva E; Dvoryakovskaya T; Kriulin I; Bracaglia C; Pardeo M; De Benedetti F; Licciardi F; Montin D; Robasto F; Minoia F; Filocamo G; Rossano M; Simonini G; Marrani E; Abu-Rumeleih S; Kostik MM; Belozerov KE; Pal P; Bathia JN; Katsicas MM; Villarreal G; Marino A; Costi S; Sztajnbok F; Silva RM; Maggio MC; El-Ghoneimy DH; El Owaidy R; Civino A; Diomeda F; Al-Mayouf SM; Al-Sofyani F; Dāvidsone Z; Patrone E; Saad-Magalhães C; Consolaro A; Ravelli A
Arthritis Rheumatol; 2024 Apr; ():. PubMed ID: 38682570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
